| 20091200.10 |
Non-frozen orange juice with a Brix value not exceeding 20 and a minimum net weight of individual packaging of ≥180 kg |
kilogram/- |
90% |
AB |
P.R/Q.S |
| 20091900.10 |
Non-frozen orange juice with a Brix value exceeding 20 and a minimum net weight of individual packaging of ≥180 kg |
kilogram/- |
90% |
AB |
R/S |
| 22029100.91 |
Contains endangered animals and plants other packaging non-alcoholic beer |
liter/kilogram |
100% |
ABEF |
R/S |
| 22029100.99 |
Other packaging non-alcoholic beer |
liter/kilogram |
100% |
AB |
R/S |
| 22029900.91 |
Others contain endangered animals and plants ingredients other packaging non-alcoholic beverages |
liter/kilogram |
100% |
ABEF |
R/S |
| 22029900.99 |
Other packaging non-alcoholic beverages |
liter/kilogram |
100% |
AB |
R/S |
| 30021300.10 |
Non-mixed immune products listed in the Doping Catalogue are not prepared with fixed dose or made into retail packaging |
kilogram/- |
20% |
ABL |
P.V/Q.W |
| 30021300.90 |
Other non-mixed immune products,not prepared in a fixed dose or in retail packaging |
kilogram/- |
20% |
AB |
P.V/Q.W |
| 30021500.50 |
Immune products listed in the Doping Catalogue have been prepared with a fixed dose or made into retail packaging |
kilogram/- |
20% |
ABL |
P.V/Q.W |
| 30021500.90 |
Other immunological products,which have been dosed or made into retail packaging for the purpose of splitting the anti-cancer drug |
kilogram/- |
20% |
AB |
P.V/Q.W |
| 30024100.11 |
The novel coronavirus (COVID-19) vaccine has been dosed or made into retail packaging |
kilogram/- |
20% |
QAB |
V/W |
| 30024100.19 |
Novel coronavirus (COVID-19) vaccine,not dosed or made into retail packaging |
kilogram/- |
20% |
QAB |
V/W |
| 30042090.99 |
Other medicines that have been dosed with other antibiotics (including made into retail packaging) |
kilogram/- |
30% |
Q |
|
| 30043200.78 |
A single dose of a dose of 1,4-androstenedione (andros-1,4-diene-3,17-dione) including its derivatives and structural analogs,free of antibiotics,including retail packaging |
kilogram/- |
30% |
L |
|
| 30043200.99 |
Other medicines containing other corticosteroids (including their derivatives and structural analogues,no antibiotics,including retail packaging),the bottom tax number generated by the separation of anticancer drugs |
kilogram/- |
30% |
Q |
|
| 30043900.99 |
Other medicines containing hormones or heading 2937 products (excluding antibiotics,including retail packaging) |
kilogram/- |
30% |
Q |
|
| 30044900.91 |
Mixed or non-mixed drugs containing alkaloids and their derivatives with anti-cancer effects,prescribed or retail packaging for treatment or disease prevention |
kilogram/- |
30% |
Q |
|
| 30044900.99 |
Other pharmaceuticals containing alkaloids and their derivatives have been dosed or made into retail packaging |
kilogram/- |
30% |
Q |
|
| 30049090.94 |
A single dose of a dose containing 2-androstene (5α-androst-2-ene-17-ol) including retail packaging |
kilogram/- |
30% |
L |
|
| 30049090.95 |
A single dose of a dose containing 3-androstene (5α-androst-3-ene-17-ol) including retail packaging |
kilogram/- |
30% |
L |
|
htshub©